Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Orexo (2 drugs' world rights)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Commercialization rights of Edluar and OX-NLA. It consists of the world wide distribution and marketing rights of the drugs Edluar and OX-NLA.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Business Products and Services
Other Industries
Distributors (Healthcare)
Acquirer
Primary Office
  • P.O. Box 303
  • 751 05 Uppsala
  • Sweden

Orexo (2 drugs' world rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Orexo (2 drugs' world rights)‘s full profile, request access.

Request full access to PitchBook

Orexo (2 drugs' world rights) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Orexo (2 drugs' world rights)‘s full profile, request access.

Request full access to PitchBook